Bayer US Pharmaceuticals’ Sebastian Guth: Designs On A New Decade

Cancer, Cardio And Culture Are Top Of Mind Targets For Tomorrow’s Top Line Growth

Guth_Sebastian_1200.jpg
Sebastian Guth, Bayer Pharmaceuticals' President For The Americas
In Vivo Podcast

Have you checked out In Vivo podcast?

New episodes every Thursday.

More from Outlook Archive

More from Outlook 2024